1. Co-Delivery of Hispolon and Doxorubicin Liposomes Improves Efficacy Against Melanoma Cells
   Ahmed Al Saqr et al, 2020, AAPS PharmSciTech CrossRef
2. Gemcitabine and Doxorubicin Combination Enhance the Cytotoxic Effect to Pancreatic Cancer Cells BxPC3 and PANC1 through UMP/CMP Kinase 1
   Shuxian Chen et al, 2017, Journal of Biosciences and Medicines CrossRef
3. Glutathione S‐transferase omega 1 inhibition activates JNK‐mediated apoptotic response in breast cancer stem cells
   Kanakaraju Manupati et al, 2019, The FEBS Journal CrossRef
4. Triptolide induces autophagy and apoptosis through ERK activation in human breast cancer MCF‑7 cells
   Huan Gao et al, 2018, Experimental and Therapeutic Medicine CrossRef
5. Protopine/Gemcitabine Combination Induces Cytotoxic or Cytoprotective Effects in Cell Type-Specific and Dose-Dependent Manner on Human Cancer and Normal Cells
   Mercedes Garcia-Gil et al, 2021, Pharmaceuticals CrossRef
6. Co-delivery of Doxorubicin and Ceramide in a Liposomal Formulation Enhances Cytotoxicity in Murine B16BL6 Melanoma Cell Lines
   Li Chen et al, 2019, AAPS PharmSciTech CrossRef
7. Synergistic and enhanced anticancer effect of a facile surface modified non-cytotoxic silver nanoparticle conjugated with gemcitabine in metastatic breast cancer cells
   Arjunan Karuppaiah et al, 2020, Materials Today Communications CrossRef
8. Decoding cell death signalling: Impact on the response of breast cancer cells to approved therapies
   Lama Lozon et al, 2024, Life Sciences CrossRef